ReviewOpen biology2025
Epstein-Barr virus functional RNAs as part of its immune evasion strategy: a role for EBER1?
Review in Open biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several types of cancer and some auto-immune diseases are linked to Epstein-Barr virus (EBV) infection. In addition to viral proteins, EBV expresses many functional RNAs to influence cell biology, avoiding the immune responses that would be targeted to viral proteins. Some of these RNAs are also exported from the EBV-infected cells into surrounding cells, including those involved in immune surveillance of the EBV infected cells. EBER1 is the most abundant of these EBV RNAs and recent progress in understanding EBER1 mechanisms might make it a drug target for some diseases associated with EBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.